Alex Zhavoronkov

About Alex Zhavoronkov

My posts and articles here are strictly personal, not reflective of positions or policies of Insilico Medicine, which disclaims any responsibility for my individual statements.I am also 100% focused on extending healthy, productive life for everyone on the planet. By citizenship, I am Canadian and Latvian. Any kind of war is against my religion, and I can not support any kind of war, military action, or disturbance of peace. I believe that countries and people need to work together to fight diseases and make the world more sustainable.In 2014, I founded Insilico Medicine a global clinical-stage generative AI drug discovery. Until 2019, it was an AI-first drug discovery company, with most of the team focused exclusively on developing and applying deep learning methods to drug discovery. Insilico is the original inventor of multiple drug discovery technologies with multiple granted and pending patents in biomarker development and generative chemistry and generative biology. In 2019 the company started working on its own therapeutic programs focusing predominantly on immunology, oncology, fibrosis, and CNS. It also made its industrial-strength target discovery platforms (PandaOmics) and generative chemistry (Chemistry42) platforms available for licensing and partnering. It raised over $500 million from expert healthcare, biotechnology, and technology investors, and entered 2 Phase II clinical trials with the novel target discovered using AI and novel molecule designed using AI. Since 2019, Insilico nominated 22 preclinical candidates, 10 reached clinical stage, 1 completed Phase 2a. I also founded, co-chair and personally sponsor the largest global non-profit conference on aging research and drug discovery - Aging Research and Drug Discovery (ARDD), In 2024, the University of Copenhagen will host 11th annual ARDD - please register early as it usually sells out in advance. Life positioning statement: record: & hl=enForbes.com articles: My book is out in English, Japanese, Chinese, and Polish:\"The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy\", Palgrave Macmillan, NY, a•••@insilico.com FB:/biogerontologyTwitter:@biogerontology

Experience

1. Scientific Advisor

   Haut.AI

   Feb 2017 — Present

   Provided valuable scientific advice and guidance to a group of bright young AI scientists on machine vision for skincare research especially in the context of aging and longevity. Advised the company CEO, Anastasia Georgievskaya, a brilliant former student and research collaborator on starting a company. Provided the team with personal research grants at first and then with seed funding to start a company and produce the MVP. Participated in several research projects related to tracking wrinkle formation, assessment of subjective age and appearance, balancing of the datasets, and series of tests to ensure race-agnostic system performance.

Education

• The Johns Hopkins University

  Master of Science, Biotechnology

• Canadian Securities Institute

  Certificate, CSC, CPH courses

• Queen's University

  Bachelor of Science, Computer Science

• Queen's University

  Bachelor of Commerce (Honors), Finance, Management of Information Systems

• NCBI, NLM, National Institutes of Health

  Certificate, NCBI Power Scripting Course

• Lomonosov Moscow State University (MSU)

  PhD, Physics

Skills

• Eu
• Rfid
• European Union
• Science
• Biochemistry
• Blogging
• Genetics
• Biogerontology
• Entrepreneurship
• Credit Risk
• Life Sciences
• Biotechnology
• Hardware Diagnostics
• Molecular Biology
• Medical Devices
• Rfid+
• Chemistry
• Retirement Solutions
• Eastern Europe
• Bioinformatics
• Vector Nti
• Gerontology
• Cell
• China Business Development
• Global Sourcing
• Cancer
• Risk Management
• Economic Modeling
• Machine Learning
• Immunology
• Russian
• Cell Biology
• Biomedical Engineering
• Regenerative Medicine
• Retirement Plan Consulting
• Pharmaceutical Industry
• Fda
• Pharmaceuticals
• China Sourcing
• Laser Physics